On June 18th, CPhI & P-MEC China 2019 was held at the Shanghai New International Expo Center. More than 3,000 biomedical companies from more than 20 countries participated in the pharmaceutical industry, including Leadership, Business, Networking, Recognition, Knowledge, Innovation. Hempsoul, a subsidiary of HMI Group, was invited as the largest industrial hemp extraction base in China, and the exporter of hemp-based pharmaceutical raw materials. Since the first day of the exhibition, it has attracted the attention of domestic and foreign buyers and media.
Hempsoul exhibited strictly tested hemp extraction products and its pioneering concept ,innovative technology, prospective research and development system.
Hempsoul also was actively shared with the all exhibitors the research progress, achievements and market transformation of international cannabis medicine in recent years, and conducted a detailed analysis and interpretation of China’s legislation and policy towards cannabis, and expressed that Hempsoul is willing to cooperate with everyone. The representatives of the company explored cooperation opportunities and actively called on the parent company HMI Group to promote the technology and resources of industrial cannabis breeding, cultivation, extraction, research and development, and sales, and promote the output of various aspects of cannabis medicine research for the benefit of the health industry.